{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:21:58Z","timestamp":1780392118991,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370608"],"award-info":[{"award-number":["82370608"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Anhui Province","award":["2208085MH204"],"award-info":[{"award-number":["2208085MH204"]}]},{"name":"the Natural Science Foundation of Education Department of Anhui Province","award":["2022AH040160"],"award-info":[{"award-number":["2022AH040160"]}]},{"name":"and the Anhui Provincial Special Fund for Clinical Medical Research Transformation","award":["202304295107020040"],"award-info":[{"award-number":["202304295107020040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05051-8","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:18:39Z","timestamp":1776705519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of the diagnostic performance and influencing factors of AFP and PIVKA-II in hepatocellular carcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Yinqiu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shucheng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"11","key":"5051_CR1","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.3390\/curroncol30110711","volume":"30","author":"F Bicer","year":"2023","unstructured":"Bicer F, Kure C, Ozluk AA, El-Rayes BF, Akce M. Advances in immunotherapy for hepatocellular carcinoma (HCC). Curr Oncol. 2023;30(11):9789\u2013812.","journal-title":"Curr Oncol"},{"issue":"8","key":"5051_CR2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3748\/wjg.v29.i8.1359","volume":"29","author":"XJ Qian","year":"2023","unstructured":"Qian XJ, Wen ZM, Huang XM, Feng HJ, Lin SS, Liu YN, et al. Better performance of PIVKA-II for detecting hepatocellular carcinoma in patients with chronic liver disease with normal total bilirubin. World J Gastroenterol. 2023;29(8):1359\u201373.","journal-title":"World J Gastroenterol"},{"key":"5051_CR3","volume":"8","author":"PJ Johnson","year":"2024","unstructured":"Johnson PJ, Bhatti E, Toyoda H, He S. Serologic detection of hepatocellular carcinoma: application of machine learning and implications for diagnostic models. JCO Clin Cancer Inform. 2024;8:e2300199.","journal-title":"JCO Clin Cancer Inform"},{"issue":"1","key":"5051_CR4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182\u2013236.","journal-title":"J Hepatol"},{"issue":"5","key":"5051_CR5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5582\/bst.2014.01116","volume":"8","author":"P Song","year":"2014","unstructured":"Song P, Feng X, Inagaki Y, Song T, Zhang K, Wang Z, et al. Clinical utility of simultaneous measurement of alpha-fetoprotein and des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: a multicenter case-controlled study of 1,153 subjects. Biosci Trends. 2014;8(5):266\u201373.","journal-title":"Biosci Trends"},{"issue":"42","key":"5051_CR6","volume":"103","author":"Y Shi","year":"2024","unstructured":"Shi Y, Yang H, Bai X, Liu X, Li Q, Du W. Female and diabetes are risk factors for alphafetoprotein and protein induced by vitamin K absence or antagonist-II negative in hepatocellular carcinoma. Medicine (Baltimore). 2024;103(42):e40100.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"5051_CR7","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/1097-0142(19891115)64:10<2117::AID-CNCR2820641024>3.0.CO;2-7","volume":"64","author":"AM Di Bisceglie","year":"1989","unstructured":"Di Bisceglie AM, Hoofnagle JH. Elevations in serum alphafetoprotein levels in patients with chronic hepatitis B. Cancer. 1989;64(10):2117\u201320.","journal-title":"Cancer"},{"issue":"22","key":"5051_CR8","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJM198405313102204","volume":"310","author":"HA Liebman","year":"1984","unstructured":"Liebman HA, Furie BC, Tong MJ, Blanchard RA, Lo KJ, Lee SD, et al. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med. 1984;310(22):1427\u201331.","journal-title":"N Engl J Med"},{"issue":"2","key":"5051_CR9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1158\/1078-0432.CCR-07-0586","volume":"14","author":"NT Zinkin","year":"2008","unstructured":"Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, Kalmowitz B, et al. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res. 2008;14(2):470\u20137.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"5051_CR10","doi-asserted-by":"crossref","first-page":"e24013","DOI":"10.1002\/jcla.24013","volume":"35","author":"J Ji","year":"2021","unstructured":"Ji J, Liu L, Jiang F, Wen X, Zhang Y, Li S, et al. The clinical application of PIVKA-II in hepatocellular carcinoma and chronic liver diseases: a multicenter study in China. J Clin Lab Anal. 2021;35(11):e24013.","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"5051_CR11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3748\/wjg.v19.i3.339","volume":"19","author":"JY Choi","year":"2013","unstructured":"Choi JY, Jung SW, Kim HY, Kim M, Kim Y, Kim DG, et al. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP. World J Gastroenterol. 2013;19(3):339\u201346.","journal-title":"World J Gastroenterol"},{"issue":"15","key":"5051_CR12","doi-asserted-by":"publisher","first-page":"7581","DOI":"10.3390\/ijms26157581","volume":"26","author":"A Farina","year":"2025","unstructured":"Farina A, Cicolani G, Viggiani V, Matteo M, Angeloni A, Anastasi E. Differential Associations of PIVKA-II with Epithelial and Mesenchymal Features in HCC and PDAC. Int J Mol Sci. 2025;26(15):7581. https:\/\/doi.org\/10.3390\/ijms26157581. Published 2025 Aug 5.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5051_CR13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/hep.1840070226","volume":"7","author":"JW Suttie","year":"1987","unstructured":"Suttie JW. Recent advances in hepatic vitamin K metabolism and function. Hepatology. 1987;7(2):367\u201376.","journal-title":"Hepatology"},{"issue":"2","key":"5051_CR14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5009\/gnl14047","volume":"9","author":"KH Kang","year":"2015","unstructured":"Kang KH, Kim JH, Kang SH, Lee BJ, Seo YS, Yim HJ, et al. The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma. Gut Liver. 2015;9(2):224\u201330.","journal-title":"Gut Liver"},{"issue":"8","key":"5051_CR15","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3390\/v14081669","volume":"14","author":"X Qian","year":"2022","unstructured":"Qian X, Liu Y, Wu F, Zhang S, Gong J, Nan Y, et al. The performance of serum alpha-fetoprotein for detecting early-stage hepatocellular carcinoma is influenced by antiviral therapy and serum aspartate aminotransferase: a study in a large cohort of hepatitis B virus-infected patients. Viruses. 2022;14(8):1669.","journal-title":"Viruses"},{"issue":"47","key":"5051_CR16","doi-asserted-by":"crossref","first-page":"16790","DOI":"10.1073\/pnas.1403053111","volume":"111","author":"N Raes","year":"2014","unstructured":"Raes N, Cannon CH, Hijmans RJ, Piessens T, Saw LG, van Welzen PC, et al. Historical distribution of Sundaland\u2019s dipterocarp rainforests at quaternary glacial maxima. Proc Natl Acad Sci USA. 2014;111(47):16790\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"5051_CR17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11135-006-9018-6","volume":"41","author":"RM O\u2019Brien","year":"2007","unstructured":"O\u2019Brien RM. A caution regarding rules of thumb for variance inflation factors. Qual Quant. 2007;41(5):673\u201390.","journal-title":"Qual Quant"},{"issue":"52","key":"5051_CR18","doi-asserted-by":"crossref","first-page":"90390","DOI":"10.18632\/oncotarget.20153","volume":"8","author":"H Chen","year":"2017","unstructured":"Chen H, Chen S, Li S, Chen Z, Zhu X, Dai M, et al. Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study. Oncotarget. 2017;8(52):90390\u2013401.","journal-title":"Oncotarget"},{"issue":"17","key":"5051_CR19","volume":"95","author":"D Ji","year":"2016","unstructured":"Ji D, Shen Y, Qin J, Feng L, Wang Y, Yang L. A systematic review of des-\u03b3-carboxy prothrombin for the diagnosis of primary hepatocellular carcinoma. Medicine (Baltimore). 2016;95(17):e3448.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"5051_CR20","doi-asserted-by":"crossref","first-page":"972","DOI":"10.29271\/jcpsp.2019.10.972","volume":"29","author":"Y Li","year":"2019","unstructured":"Li Y, Chen J. Serum des-gamma-carboxy prothrombin for diagnosis of adult primary cancer in liver. J Coll Physicians Surg Pak. 2019;29(10):972\u20136.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"39","key":"5051_CR21","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.3748\/wjg.v11.i39.6115","volume":"11","author":"CS Wang","year":"2005","unstructured":"Wang CS, Lin CL, Lee HC, Chen KY, Chiang MF, Chen HS, et al. Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma. World J Gastroenterol. 2005;11(39):6115\u20139.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"5051_CR22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1186\/s12885-017-3609-6","volume":"17","author":"R Yu","year":"2017","unstructured":"Yu R, Tan Z, Xiang X, Dan Y, Deng G. Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data. BMC Cancer. 2017;17(1):608.","journal-title":"BMC Cancer"},{"issue":"2","key":"5051_CR23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cgh.2022.01.047","volume":"21","author":"N Tayob","year":"2023","unstructured":"Tayob N, Kanwal F, Alsarraj A, Hernaez R, El-Serag HB. The performance of AFP, AFP-3, DCP as biomarkers for detection of hepatocellular carcinoma (HCC): a phase 3 biomarker study in the United States. Clin Gastroenterol Hepatol. 2023;21(2):415\u2013e4234.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"5051_CR24","first-page":"1015","volume":"58","author":"H Hadi","year":"2022","unstructured":"Hadi H, Wan Shuaib WMA, Raja Ali RA, Othman H. Utility of PIVKA-II and AFP in differentiating hepatocellular carcinoma from non-malignant high-risk patients. Med (Kaunas). 2022;58(8):1015.","journal-title":"Med (Kaunas)"},{"issue":"1","key":"5051_CR25","doi-asserted-by":"crossref","DOI":"10.3892\/br.2023.1690","volume":"20","author":"T Honda","year":"2023","unstructured":"Honda T, Ichikawa T, Yamashima M, Yamamichi S, Koike M, Nakano Y, et al. PIVKA-II is associated with liver function, bone metabolism, and muscle function in patients with liver disease. Biomed Rep. 2023;20(1):2.","journal-title":"Biomed Rep"},{"issue":"9","key":"5051_CR26","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13588","volume":"51","author":"FG Rodrigues","year":"2021","unstructured":"Rodrigues FG, Ormanji MS, Heilberg IP, Bakker SJL, de Borst MH. Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease. Eur J Clin Invest. 2021;51(9):e13588.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"5051_CR27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00198-020-05728-y","volume":"32","author":"D Ozaki","year":"2021","unstructured":"Ozaki D, Kubota R, Maeno T, Abdelhakim M, Hitosugi N. Association between gut microbiota, bone metabolism, and fracture risk in postmenopausal Japanese women. Osteoporos Int. 2021;32(1):145\u201356.","journal-title":"Osteoporos Int"},{"issue":"2","key":"5051_CR28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/ijms20020395","volume":"20","author":"I Milosevic","year":"2019","unstructured":"Milosevic I, Vujovic A, Barac A, Djelic M, Korac M, Radovanovic Spurnic A, et al. Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature. Int J Mol Sci. 2019;20(2):395.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5051_CR29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.gastro.2016.04.014","volume":"151","author":"L Moro-Sibilot","year":"2016","unstructured":"Moro-Sibilot L, Blanc P, Taillardet M, Bardel E, Couillault C, Boschetti G, et al. Mouse and human liver contain immunoglobulin A-secreting cells originating from Peyer\u2019s patches and directed against intestinal antigens. Gastroenterology. 2016;151(2):311\u201323.","journal-title":"Gastroenterology"},{"issue":"3","key":"5051_CR30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41575-020-00376-3","volume":"18","author":"J Trebicka","year":"2021","unstructured":"Trebicka J, Bork P, Krag A, Arumugam M. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure. Nat Rev Gastroenterol Hepatol. 2021;18(3):167\u201380.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"5051_CR31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2217\/bmm-2020-0691","volume":"15","author":"A Pieters","year":"2021","unstructured":"Pieters A, Gijbels E, Cogliati B, Annaert P, Devisscher L, Vinken M. Biomarkers of cholestasis. Biomark Med. 2021;15(6):437\u201354.","journal-title":"Biomark Med"},{"key":"5051_CR32","volume":"14","author":"YR Liu","year":"2014","unstructured":"Liu YR, Lin BB, Zeng DW, Zhu YY, Chen J, Zheng Q, et al. Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B. BMC Gastroenterol. 2014;14:145.","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"5051_CR33","volume":"8","author":"YH Yeo","year":"2024","unstructured":"Yeo YH, Lee YT, Tseng HR, Zhu Y, You S, Agopian VG, et al. Alpha-fetoprotein: past, present, and future. Hepatol Commun. 2024;8(5):e0422.","journal-title":"Hepatol Commun"},{"issue":"14","key":"5051_CR34","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.3748\/wjg.14.2251","volume":"14","author":"YM Zhou","year":"2008","unstructured":"Zhou YM, Yang JM, Li B, Yin ZF, Xu F, Wang B, et al. Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum \u03b1-fetoprotein. World J Gastroenterol. 2008;14(14):2251\u20134.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"5051_CR35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1499-3872(16)60095-4","volume":"15","author":"F Gao","year":"2016","unstructured":"Gao F, Zhu HK, Zhu YB, Shan QN, Ling Q, Wei XY, et al. Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern. Hepatobil Pancreat Dis Int. 2016;15(4):371\u20137.","journal-title":"Hepatobil Pancreat Dis Int"},{"issue":"2","key":"5051_CR36","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021444","volume":"5","author":"MA Buendia","year":"2015","unstructured":"Buendia MA, Neuveut C. Hepatocellular carcinoma. Cold Spring Harb Perspect Med. 2015;5(2):a021444.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"5051_CR37","first-page":"117","volume":"65","author":"NL Lazarevich","year":"2000","unstructured":"Lazarevich NL. Molecular mechanisms of alpha-fetoprotein gene expression. Biochemistry (Mosc). 2000;65(1):117\u201333.","journal-title":"Biochemistry (Mosc)"},{"issue":"10","key":"5051_CR38","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s00432-020-03331-6","volume":"146","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Zhu M, Li M. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2020;146(10):2439\u201346.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"5051_CR39","first-page":"505","volume":"13","author":"GZ Gong","year":"2005","unstructured":"Gong GZ, Jiang YF, He Y, Lai LY, Xu Y, Su XS. Molecular mechanism of HCV NS5A on p53\u2019s inhibition of AFP expression in hepatocellular carcinoma cells. Zhonghua Gan Zang Bing Za Zhi. 2005;13(7):505\u20138.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"3","key":"5051_CR40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/1096-9098(200011)75:3<197::AID-JSO8>3.0.CO;2-I","volume":"75","author":"M Matsuyama","year":"2000","unstructured":"Matsuyama M, Yamazaki O, Horii K, Higaki I, Kawai S, Mikami T, et al. Erythrocytosis caused by an erythropoietin-producing hepatocellular carcinoma. J Surg Oncol. 2000;75(3):197\u2013202.","journal-title":"J Surg Oncol"},{"issue":"6","key":"5051_CR41","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1159\/000438581","volume":"37","author":"W Sun","year":"2015","unstructured":"Sun W, Kosyna FK, Jelkmann W, Depping R. Prolyl-4-hydroxylase 2 potentially contributes to hepatocellular carcinoma associated erythrocytosis by maintaining hepatocyte nuclear factor-4\u03b1 expression. Cell Physiol Biochem. 2015;37(6):2257\u201364.","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"5051_CR42","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.21873\/invivo.12434","volume":"35","author":"M Hayashi","year":"2021","unstructured":"Hayashi M, Yamada S, Takano N, Okamura Y, Takami H, Inokawa Y, et al. Different characteristics of serum alfa-fetoprotein and serum des-gamma-carboxy prothrombin in resected hepatocellular carcinoma. In Vivo. 2021;35(3):1749\u201360.","journal-title":"In Vivo"},{"issue":"1","key":"5051_CR43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/cncr.27697","volume":"119","author":"T Li","year":"2013","unstructured":"Li T, Qin LX, Gong X, Zhou J, Sun HC, Qiu SJ, et al. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection. Cancer. 2013;119(1):126\u201335.","journal-title":"Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05051-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05051-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05051-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:54:59Z","timestamp":1780390499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05051-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5051"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05051-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the Declaration of Helsinki (1975) and received approval from Anhui Medical University Ethics Committee (approval number: 2022414). Informed Consent to Participate was obtained from the participate to conduct the study, approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have confirmed that the subjects\u2019 consent for publication has been obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"835"}}